Sunday
17:00 Registration
17:30 Poster Session and Exhibition

18:30 A human proteome resource initiative
Mathias Uhlén, Royal Institute of Technology, Stockholm Sweden

19:30 Dinner

Monday
09:00 Introduction to Swedish Proteomics Society
György Marko-Varga, AstraZeneca R&D, Lund, Sweden

09:15 A proteomics view of the plasmodium falciparum life cycle
John R Yates, Scripps Research Institute, La Jolla CA, USA

10:00 Modification-specific proteomics
Ole Noerregaard Jensen, University of Southern Denmark, Odense, Denmark

10.30 Coffee

11:00 Quantitative protein profiling of androgen-responsive proteins in human prostate cancer: application of ICAT technology to a human diseases model
Michael E Wright, University of Washington, Seattle, USA

11:30 Protein feature-based prediction of protein function
Søren Brunak, Technical University of Denmark, Lyngby, Denmark

12:00 Lunch and Exhibition

13:30 Proteomics as a tool to understand remodelling processes in disease
Gunilla Westergren-Thorsson, University of Lund, Sweden

14:00 Cancer proteomics: limitations and possibilities
Ayodele Alaiya, Karolinska Institute, Stockholm, Sweden

14:30 Protein expression profiling and PPAR activation in vivo
Bjön Dahllöf, AstraZeneca R&D, Mölndal, Sweden

15:00 Coffee and Poster session

16:00 High performance protein microarrays for drug discovery applications
Peter Oroszlan, Zeptosense AG, Witterswil, Switzerland

16:30 A model of human breast cancer progression
Jorge S Burns, University of Southern Denmark, Odense, Denmark

17:00 Manipulating the proteome
Joshua LaBaer, Harvard Medical School, Boston, USA

17:45-18:00 Swedish Proteomics Society closing remarks
György Marko-Varga, AstraZeneca R&D, Lund, Sweden